Cargando…

Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether

As artemisinin combination therapies (ACTs) are compromised by resistance, we are evaluating triple combination therapies (TACTs) comprising an amino-artemisinin, a redox drug, and a third drug with a different mode of action. Thus, here we briefly review efficacy data on artemisone, artemiside, oth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watson, Daniel J., Laing, Lizahn, Gibhard, Liezl, Wong, Ho Ning, Haynes, Richard K., Wiesner, Lubbe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284440/ https://www.ncbi.nlm.nih.gov/pubmed/34097488 http://dx.doi.org/10.1128/AAC.00990-21

Ejemplares similares

The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
por: Watson, Daniel J., et al.
Publicado: (2022)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
por: Wu, Wanting, et al.
Publicado: (2021)

Redetermination of dihydroartemisinin at 103 (2) K
por: Jasinski, Jerry P., et al.
Publicado: (2007)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
por: Ali, Shabana, et al.
Publicado: (2010)

Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids
por: Lombard, Marli C, et al.
Publicado: (2013)

Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area
por: Song , Jianping, et al.
Publicado: (2011)

Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model
por: Jang, Suyoung, et al.
Publicado: (2017)

Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
por: Ebong, Chris, et al.
Publicado: (2021)

Safety, pharmacokinetics and efficacy of artemisinins in pregnancy
por: Ades, Veronica
Publicado: (2011)

Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
por: Ebong, Chris, et al.
Publicado: (2022)

Artemisinin
Publicado: (2014)

Artemisinins: their growing importance in medicine
por: Krishna, Sanjeev, et al.
Publicado: (2008)

Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
por: Dolivo, David, et al.
Publicado: (2021)

Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review
por: Egunsola, Oluwaseun, et al.
Publicado: (2013)

The development and validation of an LC-MS/MS method for the determination of a new anti-malarial compound (TK900D) in human whole blood and its application to pharmacokinetic studies in mice
por: Abay, Efrem T, et al.
Publicado: (2014)

Assessing the asymptomatic reservoir and dihydroartemisinin–piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum
por: Falq, Grégoire, et al.
Publicado: (2016)

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
por: Tarning, Joel, et al.
Publicado: (2012)

Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects
por: Green, Justin A., et al.
Publicado: (2016)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos
por: Mayxay, Mayfong, et al.
Publicado: (2012)

Three-Dimensional Porous PVDF Foam Imprinted Membranes with High Flux and Selectivity toward Artemisinin/Artemether
por: Bian, Weibai, et al.
Publicado: (2023)

Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model
por: Abay, Efrem T, et al.
Publicado: (2015)

High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen
por: Adeel, Ahmed A., et al.
Publicado: (2015)

Cost-effectiveness of artemisinin–naphthoquine versus artemether–lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children
por: Moore, Brioni R., et al.
Publicado: (2017)

Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats
por: Li, Xiaobo, et al.
Publicado: (2022)

Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers
por: Birgersson, Sofia, et al.
Publicado: (2016)

Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
por: Daher, André, et al.
Publicado: (2019)

Pharmacokinetics and Toxicokinetics of Artemisinin-Hydroxychloroquine Sulfate Tablets in Rats and Dogs
por: Li, Xiaobo, et al.
Publicado: (2021)

Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
por: Wong, Ho Ning, et al.
Publicado: (2020)

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
por: Peto, Thomas J, et al.
Publicado: (2022)

Discovery of Artemisinin (Qinghaosu)
por: Liao, Fulong
Publicado: (2009)

Discovery and repurposing of artemisinin
por: Shi, Qiaoli, et al.
Publicado: (2022)

Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial
por: Laman, Moses, et al.
Publicado: (2014)

Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda
por: Tarning, Joel, et al.
Publicado: (2013)

Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria
por: Lohy Das, Jesmin, et al.
Publicado: (2018)

Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
por: Whegang, Solange Youdom, et al.
Publicado: (2010)

Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia
por: Tjitra, Emiliana, et al.
Publicado: (2012)

7β-Hydroxyartemisinin
por: Carvalho, Paulo B., et al.
Publicado: (2008)

Chemical stability of artemisinin derivatives
por: Van Acker, Kristel, et al.
Publicado: (2012)

Parasite proteostasis and artemisinin resistance
por: Rosenthal, Melissa, et al.
Publicado: (2023)

Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers
por: Arav-Boger, Ravit, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_onm1opicp78knsqqvlkp7q930f